According to this study, over the next five years the Nucleic Acid-Based Multiplex Assays market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Nucleic Acid-Based Multiplex Assays business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Nucleic Acid-Based Multiplex Assays market by product type, application, key companies and key regions.
This study considers the Nucleic Acid-Based Multiplex Assays value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Reagents & Consumables
Instruments & Accessories
Software & Services
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Companion Diagnostics
Research & Development
Clinical Diagnostics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Luminex
Randox Laboratories
Thermo Fisher Scientific
Bio-Rad Lab
QIAGEN
Illumina
Seegene
BD
Meso Scale Diagnostics
Abcam
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nucleic Acid-Based Multiplex Assays market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Nucleic Acid-Based Multiplex Assays market by identifying its various subsegments.
Focuses on the key global Nucleic Acid-Based Multiplex Assays players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nucleic Acid-Based Multiplex Assays with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Nucleic Acid-Based Multiplex Assays submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
Global Nucleic Acid-Based Multiplex Assays Market Growth (Status and Outlook) 2019-2024
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid-Based Multiplex Assays Market Size 2014-2024
2.1.2 Nucleic Acid-Based Multiplex Assays Market Size CAGR by Region
2.2 Nucleic Acid-Based Multiplex Assays Segment by Type
2.2.1 Reagents & Consumables
2.2.2 Reagents & Consumables
2.2.3 Software & Services
2.3 Nucleic Acid-Based Multiplex Assays Market Size by Type
2.3.1 Global Nucleic Acid-Based Multiplex Assays Market Size Market Share by Type (2014-2019)
2.3.2 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type (2014-2019)
2.4 Nucleic Acid-Based Multiplex Assays Segment by Application
2.4.1 Companion Diagnostics
2.4.2 Research & Development
2.4.3 Clinical Diagnostics
2.5 Nucleic Acid-Based Multiplex Assays Market Size by Application
2.5.1 Global Nucleic Acid-Based Multiplex Assays Market Size Market Share by Application (2014-2019)
2.5.2 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Application (2014-2019)
3 Global Nucleic Acid-Based Multiplex Assays by Players
3.1 Global Nucleic Acid-Based Multiplex Assays Market Size Market Share by Players
3.1.1 Global Nucleic Acid-Based Multiplex Assays Market Size by Players (2017-2019)
3.1.2 Global Nucleic Acid-Based Multiplex Assays Market Size Market Share by Players (2017-2019)
3.2 Global Nucleic Acid-Based Multiplex Assays Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nucleic Acid-Based Multiplex Assays by Regions
4.1 Nucleic Acid-Based Multiplex Assays Market Size by Regions
4.2 Americas Nucleic Acid-Based Multiplex Assays Market Size Growth
4.3 APAC Nucleic Acid-Based Multiplex Assays Market Size Growth
4.4 Europe Nucleic Acid-Based Multiplex Assays Market Size Growth
4.5 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size Growth
5 Americas
5.1 Americas Nucleic Acid-Based Multiplex Assays Market Size by Countries
5.2 Americas Nucleic Acid-Based Multiplex Assays Market Size by Type
5.3 Americas Nucleic Acid-Based Multiplex Assays Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Nucleic Acid-Based Multiplex Assays Market Size by Countries
6.2 APAC Nucleic Acid-Based Multiplex Assays Market Size by Type
6.3 APAC Nucleic Acid-Based Multiplex Assays Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Nucleic Acid-Based Multiplex Assays by Countries
7.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type
7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays by Countries
8.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type
8.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Nucleic Acid-Based Multiplex Assays Market Forecast
10.1 Global Nucleic Acid-Based Multiplex Assays Market Size Forecast (2019-2024)
10.2 Global Nucleic Acid-Based Multiplex Assays Forecast by Regions
10.2.1 Global Nucleic Acid-Based Multiplex Assays Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Nucleic Acid-Based Multiplex Assays Forecast by Type
10.8 Global Nucleic Acid-Based Multiplex Assays Forecast by Application
11 Key Players Analysis
11.1 Luminex
11.1.1 Company Details
11.1.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.1.3 Luminex Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Luminex News
11.2 Randox Laboratories
11.2.1 Company Details
11.2.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.2.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Randox Laboratories News
11.3 Thermo Fisher Scientific
11.3.1 Company Details
11.3.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.3.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Thermo Fisher Scientific News
11.4 Bio-Rad Lab
11.4.1 Company Details
11.4.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Bio-Rad Lab News
11.5 QIAGEN
11.5.1 Company Details
11.5.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 QIAGEN News
11.6 Illumina
11.6.1 Company Details
11.6.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.6.3 Illumina Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Illumina News
11.7 Seegene
11.7.1 Company Details
11.7.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.7.3 Seegene Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Seegene News
11.8 BD
11.8.1 Company Details
11.8.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.8.3 BD Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 BD News
11.9 Meso Scale Diagnostics
11.9.1 Company Details
11.9.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Meso Scale Diagnostics News
11.10 Abcam
11.10.1 Company Details
11.10.2 Nucleic Acid-Based Multiplex Assays Product Offered
11.10.3 Abcam Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Abcam News
12 Research Findings and Conclusion
List of Tables and Figures
Table Product Specifications of Nucleic Acid-Based Multiplex Assays
Figure Nucleic Acid-Based Multiplex Assays Report Years Considered
Figure Market Research Me